In the wake of President Donald Trump’s $6 billion proposed cut to the National Institutes of Health, biotech executives and researchers are slated to meet with the new administration next month.
A memo about the meeting reportedly describes the get-together as a chance for the “private sector and thought leaders to describe their institution and its connection to federal funding.”
Get the full story at our sister site, Drug Delivery Business News.